
The global Immunology market size was valued at USD 66090 million in 2023 and is forecast to a readjusted size of USD 100840 million by 2030 with a CAGR of 6.2% during review period.
The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.
One of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body's immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the following years.
Report includes an overview of the development of the Immunology industry chain, the market status of Autoimmune Diseases (Immuno Boosters, Immunosuppressants), Oncology (Immuno Boosters, Immunosuppressants), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immunology.
Regionally, the report analyzes the Immunology markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immunology market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immunology market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immunology industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immuno Boosters, Immunosuppressants).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immunology market.
Regional Analysis: The report involves examining the Immunology market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immunology market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immunology:
Company Analysis: Report covers individual Immunology players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immunology This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Autoimmune Diseases, Oncology).
Technology Analysis: Report covers specific technologies relevant to Immunology. It assesses the current state, advancements, and potential future developments in Immunology areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immunology market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Immunology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Immuno Boosters
Immunosuppressants
麻豆原创 segment by Application
Autoimmune Diseases
Oncology
Organ Transplantation
Others
麻豆原创 segment by players, this report covers
AbbVie
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Bionor Pharma
Celgene
Cellectar Biosciences
eFFECTOR Therapeutics
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immunology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immunology, with revenue, gross margin and global market share of Immunology from 2019 to 2024.
Chapter 3, the Immunology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immunology market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunology.
Chapter 13, to describe Immunology research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Immunology
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Immunology by Type
1.3.1 Overview: Global Immunology 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Immunology Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Immuno Boosters
1.3.4 Immunosuppressants
1.4 Global Immunology 麻豆原创 by Application
1.4.1 Overview: Global Immunology 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Autoimmune Diseases
1.4.3 Oncology
1.4.4 Organ Transplantation
1.4.5 Others
1.5 Global Immunology 麻豆原创 Size & Forecast
1.6 Global Immunology 麻豆原创 Size and Forecast by Region
1.6.1 Global Immunology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Immunology 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Immunology 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Immunology 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Immunology 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Immunology 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Immunology 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Immunology Product and Solutions
2.1.4 AbbVie Immunology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Immunology Product and Solutions
2.2.4 Amgen Immunology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Amgen Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business
2.3.3 F. Hoffmann-La Roche Immunology Product and Solutions
2.3.4 F. Hoffmann-La Roche Immunology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Immunology Product and Solutions
2.4.4 Johnson & Johnson Immunology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Bionor Pharma
2.5.1 Bionor Pharma Details
2.5.2 Bionor Pharma Major Business
2.5.3 Bionor Pharma Immunology Product and Solutions
2.5.4 Bionor Pharma Immunology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Bionor Pharma Recent Developments and Future Plans
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business
2.6.3 Celgene Immunology Product and Solutions
2.6.4 Celgene Immunology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Celgene Recent Developments and Future Plans
2.7 Cellectar Biosciences
2.7.1 Cellectar Biosciences Details
2.7.2 Cellectar Biosciences Major Business
2.7.3 Cellectar Biosciences Immunology Product and Solutions
2.7.4 Cellectar Biosciences Immunology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Cellectar Biosciences Recent Developments and Future Plans
2.8 eFFECTOR Therapeutics
2.8.1 eFFECTOR Therapeutics Details
2.8.2 eFFECTOR Therapeutics Major Business
2.8.3 eFFECTOR Therapeutics Immunology Product and Solutions
2.8.4 eFFECTOR Therapeutics Immunology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 eFFECTOR Therapeutics Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Immunology Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Immunology by Company Revenue
3.2.2 Top 3 Immunology Players 麻豆原创 Share in 2023
3.2.3 Top 6 Immunology Players 麻豆原创 Share in 2023
3.3 Immunology 麻豆原创: Overall Company Footprint Analysis
3.3.1 Immunology 麻豆原创: Region Footprint
3.3.2 Immunology 麻豆原创: Company Product Type Footprint
3.3.3 Immunology 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Immunology Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Immunology 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Immunology Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Immunology 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Immunology Consumption Value by Type (2019-2030)
6.2 North America Immunology Consumption Value by Application (2019-2030)
6.3 North America Immunology 麻豆原创 Size by Country
6.3.1 North America Immunology Consumption Value by Country (2019-2030)
6.3.2 United States Immunology 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Immunology 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Immunology 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Immunology Consumption Value by Type (2019-2030)
7.2 Europe Immunology Consumption Value by Application (2019-2030)
7.3 Europe Immunology 麻豆原创 Size by Country
7.3.1 Europe Immunology Consumption Value by Country (2019-2030)
7.3.2 Germany Immunology 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Immunology 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Immunology 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Immunology 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Immunology 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Immunology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Immunology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Immunology 麻豆原创 Size by Region
8.3.1 Asia-Pacific Immunology Consumption Value by Region (2019-2030)
8.3.2 China Immunology 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Immunology 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Immunology 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Immunology 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Immunology 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Immunology 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Immunology Consumption Value by Type (2019-2030)
9.2 South America Immunology Consumption Value by Application (2019-2030)
9.3 South America Immunology 麻豆原创 Size by Country
9.3.1 South America Immunology Consumption Value by Country (2019-2030)
9.3.2 Brazil Immunology 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Immunology 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Immunology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Immunology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Immunology 麻豆原创 Size by Country
10.3.1 Middle East & Africa Immunology Consumption Value by Country (2019-2030)
10.3.2 Turkey Immunology 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Immunology 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Immunology 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Immunology 麻豆原创 Drivers
11.2 Immunology 麻豆原创 Restraints
11.3 Immunology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Immunology Industry Chain
12.2 Immunology Upstream Analysis
12.3 Immunology Midstream Analysis
12.4 Immunology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
AbbVie
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Bionor Pharma
Celgene
Cellectar Biosciences
eFFECTOR Therapeutics
听
听
*If Applicable.
